Jane Street Group, LLC Charles River Laboratories International, Inc. Call Options Transaction History

Jane Street Group, LLC

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$187.96 - $245.29 $6.24 Million - $8.14 Million	33,200 New	33,200 $6.54 Million
Q4 2021 Feb 15, 2022	SELL	$351.38 - $448.68 $2.46 Million - $3.14 Million	-7,000 Reduced 9.38%	67,600 $25.5 Million
Q3 2021 Nov 16, 2021	BUY	$372.64 - $458.3 $2.83 Million - $3.48 Million	7,600 Added 11.34%	74,600 $30.8 Million
Q2 2021 Aug 16, 2021	BUY	$294.17 - $371.65 $11 Million - $13.9 Million	37,400 Added 126.35%	67,000 $24.8 Million
Q1 2021 May 18, 2021	BUY	$249.67 - $299.48 $7.02 Million - $8.42 Million	28,100 Added 1873.33%	29,600 $8.58 Million
Q4 2020 Feb 17, 2021	SELL	$222.0 - $252.62 $2.82 Million - $3.21 Million	-12,700 Reduced 89.44%	1,500 $375,000
Q3 2020 Nov 17, 2020	SELL	$175.56 - $226.45 $10.7 Million - $13.7 Million	-60,700 Reduced 81.04%	14,200 $3.22 Million
Q2 2020 Aug 17, 2020	BUY	$118.84 - $189.72 $8.9 Million - $14.2 Million	74,900 New	74,900 $13.1 Million

694

52.2M

259K

463K

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $9.29B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.